Ignite Creation Date:
2025-12-24 @ 11:40 PM
Ignite Modification Date:
2026-01-18 @ 12:32 PM
Study NCT ID:
NCT00430651
Status:
COMPLETED
Last Update Posted:
2009-01-28
First Post:
2007-02-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Docetaxel and Carboplatin Versus Docetaxel as Second Line Treatment in Patients With Non-Small-Cell Lung Carcinoma (NSCLC)
Sponsor:
Hellenic Oncology Research Group
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
CT/04.14
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
V.Georgoulias
Old Organization:
Hellenic Oncology Research Group
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | OTHER | View |